Literature DB >> 23678179

Increased early RNA replication by chimeric West Nile virus W956IC leads to IPS-1-mediated activation of NF-κB and insufficient virus-mediated counteraction of the resulting canonical type I interferon signaling.

S V Scherbik1, J A Pulit-Penaloza, M Basu, S C Courtney, M A Brinton.   

Abstract

Although infections with "natural" West Nile virus (WNV) and the chimeric W956IC WNV infectious clone virus produce comparable peak virus yields in type I interferon (IFN) response-deficient BHK cells, W956IC infection produces higher levels of "unprotected" viral RNA at early times after infection. Analysis of infections with these two viruses in IFN-competent cells showed that W956IC activated NF-κB, induced higher levels of IFN-β, and produced lower virus yields than WNV strain Eg101. IPS-1 was required for both increased induction of IFN-β and decreased yields of W956IC. In Eg101-infected cells, phospho-STAT1/STAT2 nuclear translocation was blocked at all times analyzed, while some phospho-STAT1/STAT2 nuclear translocation was still detected at 8 h after infection in W956IC-infected mouse embryonic fibroblasts (MEFs), and early viral protein levels were lower in these cells. A set of additional chimeras was made by replacing various W956IC gene regions with the Eg101 equivalents. As reported previously, for three of these chimeras, the low early RNA phenotype of Eg101 was restored in BHK cells. Analysis of infections with two of these chimeric viruses in MEFs detected lower early viral RNA levels, higher early viral protein levels, lower early IFN-β levels, and higher virus yields similar to those seen after Eg101 infection. The data suggest that replicase protein interactions directly or indirectly regulate genome switching between replication and translation at early times in favor of translation to minimize NF-κB activation and IFN induction by decreasing the amount of unprotected viral RNA, to produce sufficient viral protein to block canonical type I IFN signaling, and to efficiently remodel cell membranes for exponential genome amplification.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23678179      PMCID: PMC3700190          DOI: 10.1128/JVI.02842-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  An infectious clone of the West Nile flavivirus.

Authors:  V F Yamshchikov; G Wengler; A A Perelygin; M A Brinton; R W Compans
Journal:  Virology       Date:  2001-03-15       Impact factor: 3.616

2.  Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East.

Authors:  Robert S Lanciotti; Gregory D Ebel; Vincent Deubel; Amy J Kerst; Severine Murri; Richard Meyer; Michael Bowen; Nancy McKinney; William E Morrill; Mary B Crabtree; Laura D Kramer; John T Roehrig
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

Review 3.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

4.  Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype.

Authors:  David W C Beasley; Li Li; Miguel T Suderman; Alan D T Barrett
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

5.  IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA.

Authors:  Kristi L Peters; Heather L Smith; George R Stark; Ganes C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 6.  The molecular biology of West Nile Virus: a new invader of the western hemisphere.

Authors:  Margo A Brinton
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

7.  Differential expression of interferon (IFN) regulatory factors and IFN-stimulated genes at early times after West Nile virus infection of mouse embryo fibroblasts.

Authors:  Svetlana V Scherbik; Bronislava M Stockman; Margo A Brinton
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

8.  The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway.

Authors:  Brenda L Fredericksen; Maria Smith; Michael G Katze; Pei-Yong Shi; Michael Gale
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  Inhibition of interferon signaling by dengue virus.

Authors:  Jorge L Muñoz-Jordan; Gilma G Sánchez-Burgos; Maudry Laurent-Rolle; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

View more
  11 in total

1.  RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.

Authors:  J C Madden; Dan Cui; M A Brinton
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 2.  Functions of the 3' and 5' genome RNA regions of members of the genus Flavivirus.

Authors:  Margo A Brinton; Mausumi Basu
Journal:  Virus Res       Date:  2015-02-13       Impact factor: 3.303

3.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

4.  Two Interferon-Stimulated Response Elements Cooperatively Regulate Interferon-Stimulated Gene Expression in West Nile Virus-Infected IFNAR-/- Mouse Embryo Fibroblasts.

Authors:  Dan Cui; Emilio E Espínola; Komal Arora; Margo A Brinton
Journal:  J Virol       Date:  2021-09-08       Impact factor: 5.103

5.  Comparison of attenuated and virulent West Nile virus strains in human monocyte-derived dendritic cells as a model of initial human infection.

Authors:  Daniel J Rawle; Yin Xiang Setoh; Judith H Edmonds; Alexander A Khromykh
Journal:  Virol J       Date:  2015-03-22       Impact factor: 4.099

6.  G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA.

Authors:  Katell Bidet; Dhivya Dadlani; Mariano A Garcia-Blanco
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

7.  Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile virus (WNV).

Authors:  Pauline E Chugh; Blossom A Damania; Dirk P Dittmer
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

8.  Arsenite-induced stress granule formation is inhibited by elevated levels of reduced glutathione in West Nile virus-infected cells.

Authors:  Mausumi Basu; Sean C Courtney; Margo A Brinton
Journal:  PLoS Pathog       Date:  2017-02-27       Impact factor: 6.823

9.  Delayed antibody dependent enhancement of low passage dengue virus 4 isolates.

Authors:  Nitwara Wikan; Sirikwan Libsittikul; Sutee Yoksan; Prasert Auewarakul; Duncan R Smith
Journal:  BMC Res Notes       Date:  2015-09-02

Review 10.  Replication cycle and molecular biology of the West Nile virus.

Authors:  Margo A Brinton
Journal:  Viruses       Date:  2013-12-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.